Trials / Completed
CompletedNCT02884791
FGF21 and Fructose Challenge in Humans
Fibroblast Growth Factor 21 and Fructose Challenge in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The primary aim of this study is to examine the effect of acute ingestion of fructose on serum FGF21 levels. Subjects in this study will be lean volunteers and individuals with metabolic syndrome.
Detailed description
Participation in this study involves fasting overnight, drinking a sweet beverage, and several blood draws through an IV line. Each subject may drink up to 10 different sweet beverages, separated by 2 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | oral carbohydrate challenge | Participants will fast for 8 hours and then drink a beverage containing fructose. |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2023-05-30
- Completion
- 2023-05-30
- First posted
- 2016-08-31
- Last updated
- 2023-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02884791. Inclusion in this directory is not an endorsement.